Dr. Amanda Adler

Biography

Amanda Adler is a Professor of Diabetic Medicine and holds the Health Policy Chair at the Radcliffe Department of Medicine, University of Oxford. She has a strong background in economics, medicine, and pharmacovigilance, with expertise in pharmacoepidemiology. She collaborates with the Health Economic Research Centre and has been actively involved in clinical trials and health economic projects in the UK and internationally. As a practicing clinician, she teaches the Management of Medicines Programme at Green Templeton College, alongside the MSc Clinical Trials and Economics Health Care short course. Amanda supervises DPhil and Masters students and mentors NIHR academic clinical fellows and career development awardees. She is a Commissioner for the Commission on Human Medicines (CHM), advising on the safety, efficacy, and quality of medicinal products, and chairs its Expert Advisory Group on Cardiovascular, Diabetes, Renal, and Respiratory Allergy. Amanda has chaired the NIHR Clinical Evaluation Trials Funding Committee and led various guideline committees for the WHO and the Pan American Health Organisation focusing on type 2 diabetes management in primary care. She also served as chair of the Technology Appraisal Committee at NICE for twelve years, evaluating drugs and devices across multiple disease areas, and received the Distinguished Contribution award from NICE.

Research Interests